Serum amyloid A in equine health and disease.
Authors: Witkowska-Piłaszewicz O D, Żmigrodzka M, Winnicka A, Miśkiewicz A, Strzelec K, Cywińska A
Journal: Equine veterinary journal
Summary
# Editorial Summary: Serum Amyloid A in Equine Health and Disease Serum amyloid A (SAA) functions as the primary acute phase protein in horses, rising sharply in response to any systemic inflammatory stimulus—from infection and tissue injury to surgical intervention—whilst remaining negligibly low in healthy individuals. The utility of SAA as a diagnostic and monitoring tool stems from its rapid turnover; the short half-life means that blood concentrations accurately track the timeline of inflammatory onset and resolution, providing real-time insight into disease progression and treatment efficacy. The authors reviewed published evidence demonstrating elevated SAA across gastrointestinal, reproductive, and respiratory conditions, and notably in post-operative recovery, alongside emerging applications in identifying subclinical pathologies that might otherwise compromise equine athletic performance. With point-of-care and laboratory testing increasingly accessible in clinical practice, SAA measurement offers practitioners a non-specific but highly sensitive biomarker for distinguishing inflammatory states from other causes of poor performance or ill-health. For farriers, veterinarians, physiotherapists and nutritionists involved in equine care, incorporating SAA testing into diagnostic protocols—particularly when evaluating subtle lameness, training response, or systemic illness—provides an objective measure of inflammatory burden independent of clinical signs alone.
Read the full abstract on PubMed
Practical Takeaways
- •SAA is a reliable blood biomarker for assessing inflammatory status in horses and can identify horses with subclinical inflammation affecting performance
- •Because SAA responds quickly to inflammation onset and resolves with short half-life, serial measurements effectively monitor disease progression and treatment efficacy
- •Availability of both laboratory and point-of-care SAA testing makes this a practical diagnostic tool for field practitioners to establish health status objectively
Key Findings
- •Serum amyloid A is the major acute phase protein in horses with very low concentration in healthy animals but increases dramatically with inflammation
- •SAA has a short half-life making it useful for detecting the onset of inflammation and monitoring response to treatment
- •SAA increases have been documented across multiple disease categories including digestive, reproductive, respiratory diseases and following surgical procedures
- •SAA measurement can detect subclinical pathologies that may impair training and competition performance in equine athletes